GINKGO BIOWORKS HOLDINGS, INC. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
GINKGO BIOWORKS HOLDINGS, INC. (DNA) had Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount of $91.81 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount · last filed 2026-08-06
- 2026-06-30: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $91.81M.
- 2026-03-31: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $91.81M.
- 2025-09-30: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $77.31M.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount |
|---|---|
| 2026-06-30 | $91.81M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $91.81M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $77.31M 10-Q · filed 2025-11-06 |